Ceeto Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Hold
3,030
0.98% 20
2026
Q1
$2.79M Buy
3,030
+300
+11% +$304K 0.86% 28
2025
Q4
$2.93M Hold
2,730
0.86% 25
2025
Q3
$2.08M Buy
2,730
+1,000
+58% +$744K 0.6% 34
2025
Q2
$1.35M Buy
1,730
+100
+6% +$77.7K 0.47% 53
2025
Q1
$1.35M Hold
1,630
0.51% 43
2024
Q4
$1.26M Hold
1,630
0.46% 44
2024
Q3
$1.44M Sell
1,630
-1,000
-38% -$899K 0.54% 40
2024
Q2
$2.38M Buy
2,630
+500
+23% +$400K 0.92% 19
2024
Q1
$1.66M Buy
2,130
+100
+5% +$71.2K 0.68% 39
2023
Q4
$1.18M Hold
2,030
0.51% 47
2023
Q3
$1.09M Hold
2,030
0.53% 46
2023
Q2
$952K Hold
2,030
0.44% 52
2023
Q1
$697K Hold
2,030
0.35% 63
2022
Q4
$743K Buy
2,030
+1,030
+103% +$365K 0.41% 60
2022
Q3
$323K Hold
1,000
0.19% 113
2022
Q2
$324K Buy
+1,000
New +$300K 0.18% 112

Other funds holding LLY

Ceeto Capital Group's LLY Position: Q2 2026 in Review

Ceeto Capital Group held its Eli Lilly (LLY) position steady in Q2 2026 at 3,030 shares worth $3.63M. The position accounts for 0.98% of the portfolio, ranked #20.

Ceeto Capital Group first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ceeto Capital Group held 3,030 shares of Eli Lilly worth $3.63M as of Q2 2026.
  • Ceeto Capital Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.98% of Ceeto Capital Group's portfolio in Q2 2026, its #20 holding.
  • Ceeto Capital Group first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ceeto Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.